21 reports

The Pharma Innovation; ##(##): ##-## Bresnick GH (1983).

  • Eye Disease
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • RXi Pharmaceuticals Corporation

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2016 Social Media Advertising Spend in China, 2016 Databook List of Figures List of Tables ##.

  • Advertising
  • Computer
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Brands pay for space on one or more of the online company' s pages to display a static or linked banner or logo.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • RXI PHARMACEUTICALS CORP, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • RXI PHARMACEUTICALS CORP, SUBSIDIARIES

Summary RXi Pharmaceuticals Corp (RXi) is a biotechnology company that discovers, develops and commercializes immuno-oncology therapeutics to treat cancer.The company’s technology sd-rxRNA includes RXI-109 and IncRNA. Its lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of connective tissue...

  • Biological Therapy
  • Healthcare
  • Pharmaceutical
  • Therapy
  • RXi Pharmaceuticals Corporation

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2015 Social Media Advertising Spend in China, 2015 Databook List of Figures List of Tables ##.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Digital Advertising Spend in China, 2015 Databook REFERENCE CODE: DSDB## PUBLISHED: APRIL 2015 LIST OF FIGURES LIST OF TABLES ##.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • INTERIM BALANCE SHEET - (ACTUAL VALUES): RXI PHARMACEUTICALS CORP
  • WRIGHT QUALITY RATING - FINANCIAL STRENGTH: RXI PHARMACEUTICALS CORP

A textual analysis of the financial results for RXi Pharmaceuticals Corp compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact...

  • Pharmaceutical
  • United States
  • Company Financials
  • RXi Pharmaceuticals Corporation
  • VALUATION MULTIPLES (RXI PHARMACEUTICALS CORPORATION)
  • VALUATION MULTIPLES (RXI PHARMACEUTICALS CORPORATION)

RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers...

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • RXi Pharmaceuticals Corporation
  • VALUATION MULTIPLES (RXI PHARMACEUTICALS CORPORATION)
  • VALUATION MULTIPLES (RXI PHARMACEUTICALS CORPORATION)

RXi Pharmaceuticals Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers...

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • RXi Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORPORATION SNAPSHOT
  • RXI PHARMACEUTICALS CORPORATION - RESEARCH AND DEVELOPMENT OVERVIEW

RXi Pharmaceuticals Corporation - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘RXi Pharmaceuticals Corporation - Product Pipeline Review - 2016’, provides an overview of the RXi Pharmaceuticals Corporation’s pharmaceutical research and development focus. The report provides comprehensive information...

  • Pharmaceutical
  • Research And Development
  • RNAi Technology
  • Therapy
  • RXi Pharmaceuticals Corporation
  • PROMORE PHARMA
  • RXI PHARMACEUTICALS CORP

Scar - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Scar - Pipeline Review, H2 2017, provides an overview of the Scar (Dermatology) pipeline landscape. A scar is a permanent patch of skin that grows over a wound. Scars occur at the site of...

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORP
  • PROLIFERATIVE VITREORETINOPATHY (PVR) - PIPELINE BY RXI PHARMACEUTICALS CORP, H1 2017

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Vitreoretinopathy (PVR) – Pipeline Review, H1 2017, provides an overview of the Proliferative Vitreoretinopathy (PVR) (Ophthalmology) pipeline landscape. Proliferative...

  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • PROMORE PHARMA
  • RXI PHARMACEUTICALS CORP

Scar - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Scar - Pipeline Review, H1 2018, provides an overview of the Scar (Dermatology) pipeline landscape. A scar is a permanent patch of skin that grows over a wound. Scars...

  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORP
  • TOPADUR PHARMA AG

Keloids - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Keloids - Pipeline Review, H1 2018, provides an overview of the Keloids (Dermatology) pipeline landscape. Keloids are a growth of extra scar tissue where the skin...

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • TOPADUR PHARMA AG
  • RXI PHARMACEUTICALS CORP

Keloids - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Keloids - Pipeline Review, H2 2017, provides an overview of the Keloids (Dermatology) pipeline landscape. Keloids are a growth of extra scar tissue where the skin...

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORPORATION
  • PIPELINE BY RXI PHARMACEUTICALS CORPORATION, H1 2016

Connective Tissue Growth Factor (Insulin-Like Growth Factor-Binding Protein 8 or Hypertrophic Chondrocyte-Specific Protein 24) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Connective Tissue Growth Factor (Insulin-Like Growth Factor-Binding Protein 8 or Hypertrophic Chondrocyte-Specific Protein 24) - Pipeline...

  • Cell Therapy
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • PARTNER 2: CYTRX CORPORATION
  • PARTNERSHIP - DEAL REPORTS

University of Massachusetts Medical School - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s University of Massachusetts Medical School Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed...

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • RXi Pharmaceuticals Corporation
  • CORPORATE VENTURING - DEAL REPORTS

Target Acquirer ## Acquirer ## Tesla Motors, Inc.

  • Pharmaceutical
  • China
  • Company
  • M&A
  • Tencent Holdings Ltd
  • CORPORATE VENTURING - DEAL REPORTS

Target Acquirer ## Acquirer ## Tesla Motors, Inc.

  • Pharmaceutical
  • China
  • Company
  • M&A
  • Tencent Holdings Ltd
  • HYPERTROPHIC SCARS - PIPELINE BY RXI PHARMACEUTICALS CORPORATION, H2 2015
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2015

Hypertrophic Scars - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Hypertrophic Scars - Pipeline Review, H2 2015’, provides an overview of the Hypertrophic Scars’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hypertrophic Scars, complete with...

  • Pharmaceutical
  • Research And Development
  • Therapy
  • United States
  • RXi Pharmaceuticals Corporation
  • CORPORATE VENTURING - DEAL REPORTS

Target Acquirer ## Acquirer ## Tesla Motors, Inc.

  • Pharmaceutical
  • China
  • Company
  • M&A
  • Tencent Holdings Ltd